帕珠丸对慢性乙醇性肝损伤大鼠PPAR-1 与AMPK-1的影响

穆志龙; 任世存

doi:10.13422/j.cnki.syfix.2014080146

您当前的位置：

首页 >

文章列表页 >

帕珠丸对慢性乙醇性肝损伤大鼠PPAR-1 与AMPK-1的影响

更新时间：2024-01-04

- 帕珠丸对慢性乙醇性肝损伤大鼠PPAR-1 与AMPK-1的影响
- Impact of Pazufloxacin Pill on PPAR-1, AMPK-1 in Rats with Chronic Alcoholic Liver Injury
- 中国实验方剂学杂志 2014年20卷第8期页码：146-150
- 作者机构：
- 作者简介：
- 基金信息：
  
  青海省科技厅重点科技基金项目（2012-Z-709）
- DOI：10.13422/j.cnki.syfix.2014080146
  中图分类号：
- 纸质出版日期：2014
- 稿件说明：
移动端阅览
穆志龙, 任世存. 帕珠丸对慢性乙醇性肝损伤大鼠PPAR-1 与AMPK-1的影响[J]. 中国实验方剂学杂志, 2014,20(8):146-150.

MU Zhi-long, REN Shi-cun. Impact of Pazufloxacin Pill on PPAR-1, AMPK-1 in Rats with Chronic Alcoholic Liver Injury[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(8): 146-150.
穆志龙, 任世存. 帕珠丸对慢性乙醇性肝损伤大鼠PPAR-1 与AMPK-1的影响[J]. 中国实验方剂学杂志, 2014,20(8):146-150. DOI： 10.13422/j.cnki.syfix.2014080146.

MU Zhi-long, REN Shi-cun. Impact of Pazufloxacin Pill on PPAR-1, AMPK-1 in Rats with Chronic Alcoholic Liver Injury[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(8): 146-150. DOI： 10.13422/j.cnki.syfix.2014080146.

摘要

目的：观察帕珠丸对乙醇性肝损伤大鼠肝组织中过氧化物酶体增殖物激活受体α1 （PPAR-α1）及腺苷酸活化蛋白激酶α1（AMPK-α1）表达水平的影响及探讨其对肝脏的保护作用。方法：将78只纯系雄性SD大鼠随机分成正常对照组、模型对照组、联苯双酯组、帕珠丸低、中、高剂量组6组。模型组、联苯双酯组、帕珠丸低、中、高剂量组分别给予56%红星二锅头酒10 mL·kg-1灌胃；正常组给予10 mL·kg-1生理盐水灌胃，每天上午1次，连续灌胃12周，复制乙醇性肝损伤模型。造模成功后，帕珠丸低、中、高剂量组分别给予10 mL·kg-1帕珠丸混悬液灌胃，剂量依次为0.05，0.10，0.20 g·kg-1；联苯双酯组给予10 mL·kg-1联苯双酯滴丸混悬液灌胃，剂量为0.003 g·kg-1；正常对照组、模型对照组分别给予同体积生理盐水灌胃，各组每天上午灌胃1次，连续灌胃3周。检测血清丙氨酸转氨酶（ALT）、天门冬氨酸转氨酶（AST）的活性及甘油三酯（TG）的水平，并检测肝组织中PPAR-α1 mRNA、AMPK-α1 mRNA的表达水平。结果：与正常组比较，模型组大鼠血清肝脏湿重和肝指数以及ALT，AST，TG，均显著升高（P<0.05），模型组大鼠肝组织中PPAR-α1 mRNA，AMPK-α1 mRNA显著降低（P<0.01）。与模型组比较，帕珠丸各剂量组与联苯双酯组肝脏湿重和肝指数及ALT，AST，TG均显著降低（P<0.05）；与模型组比较，帕珠丸各剂量组与联苯双酯组PPAR-α1 mRNA，AMPK-α1 mRNA均显著升高（P<0.05）。结论：帕珠丸可上调肝组织内PPAR-α1 mRNA，AMPK-α1 mRNA的表达，提示该药对乙醇性肝病有一定的保护作用。

Abstract

Objective: To observe the impact of Pazufloxacin pill on alcoholic liver injury in rats with peroxisome proliferators activator receptors alphα 1(PPAR-α1)

AMP acitvated kinase-α1(AMPK-α1) and explore its protective effect on the liver. Method: The 78 inbred male SD rats were randomly divided into normal control group

model group

diphenyl dimethyl bicarboxy late(DDB) group

Pazufloxacin pill low

medium and high dose groups 6 groups. Model group

DDB group

Pazufloxacin pill low

medium and high dose groups were given 56% of the Red Star Erguotou wine 10 mL·kg-1 gavage;given normal saline 10 mL·kg-1

every morning a second consecutive gavage 12 weeks;to copy ethanol-induced liver injury model. After the modeling

Pazufloxacin pills low

medium and high dose groups were given 10 mL·kg-1 Pazufloxacin pill suspension gavage

Doses were 0.05

0.10

0.20 g·kg-1;DDB group was given 10 mL·kg-1suspension drop pills orally

at a dose of 0.003 g·kg-1;normal control group

model control group were given the same volume of saline

administered once a day in each group

continuous gavage three weeks. The serum alanine aminotransferase (ALT)

aspartate aminotransferase (AST) activity and triglyceride (TG) levels were measured

and liver tissue PPAR-α1 mRNA

AMPK-α1 mRNA expression levels were detected. Result: Compared with normal group

model group

serum liver wet weight and liver index and ALT

AST

were significantly increased (P<0.05)

model group rat liver tissue PPAR-α1 mRNA

AMPK-α1 mRNA was significantly lower (P<0.01). Compared with model group

in Pazufloxacin pill each dose group and the DDB group liver wet weight and liver index and ALT

AST

TG levels were significantly lower (P<0.05);Compared with model group

in Pa beads pill each dose group and DDB group PPAR-α1 mRNA

AMPK-α1 mRNA were significantly increased (P<0.05). Conclusion: Pazufloxacin pill can increase the liver tissue PPAR-α1 mRNA

AMPK-α1 mRNA expression.It is pointed that the drugs have a protective effect on treating alcoholic liver disease.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

葛根散对酒精性ED大鼠阴茎平滑肌组织结构NOS活力及α-SMA，Cx43，TGF-β₁ mRNA和蛋白表达的影响

大鼠慢性浅表性胃炎模型的建立